Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan-Feb;15(1):74-84.
doi: 10.1097/ADM.0000000000000739.

Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review

Affiliations
Review

Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review

Brian Chan et al. J Addict Med. 2021 Jan-Feb.

Abstract

Objectives: Although medications for opioid use disorder (MOUD) save lives, treatment retention remains challenging. Identification of interventions to improve MOUD retention is of interest to policymakers and researchers. On behalf of the Agency for Healthcare Research and Quality, we conducted a rapid evidence review on interventions to improve MOUD retention.

Methods: We searched MEDLINE and the Cochrane Library from February 2009 through August 2019 for systematic reviews and randomized trials of care settings, services, logistical support, contingency management, health information technology (IT), extended-release (XR) formulations, and psychosocial interventions that assessed retention at least 3 months.

Results: Two systematic reviews and 39 primary studies were included; most did not focus on retention as the primary outcome. Initiating MOUD in soon-to-be-released incarcerated people improved retention following release. Contingency management may improve retention using antagonist but not agonist MOUD. Retention with interventions integrating medical, psychiatric, social services, or IT did not differ from in-person treatment-as-usual approaches. Retention was comparable with XR- compared to daily buprenorphine formulations and conflicting with XR-naltrexone monthly injection compared to daily buprenorphine. Most psychosocial interventions did not improve retention.

Discussion: Consistent but sparse evidence supports criminal justice prerelease MOUD initiation, and contingency management interventions for antagonist MOUD. Integrating MOUD with medical, psychiatric, social services, delivering through IT, or administering via XR-MOUD formulations did not worsen retention. Fewer than half of the studies we identified focused on retention as a primary outcome. Studies used different measures of retention, making it difficult to compare effectiveness. Additional inquiry into the causes of low retention would inform future interventions.Registration: PROSPERO: CRD42019134739.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Analytic framework for improving retention in medications for opioid use disorder for opioid use disorder.
FIGURE 2
FIGURE 2
Literature flow diagram.
FIGURE 3
FIGURE 3
Spectrum of IT interventions proposed to increase MOUD retention. Apps, applications; CBT, cognitive behavioral therapy; GPS, global positioning system; HER, electronic health record; This figure adapted from the Office of the National Coordinator for Health IT Playbook definition and categorization of health IT.

Comment in

References

    1. Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder 2018. - PubMed
    1. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths—United States, 2013–2017. MMWR Morb Mortal Wkly Rep 2019; 67 (5152):1419. - PMC - PubMed
    1. Van Handel MM, Rose CE, Hallisey EJ, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr 2016; 73 (3):323. - PMC - PubMed
    1. National Academies of Sciences Engineering, Medicine. Medications for Opioid Use Disorder Save Lives. Washington, DC: The National Academies Press; 2019. - PubMed
    1. Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry 2019; 76 (2):208–216. - PubMed

Publication types